20 research outputs found
The relation between biodiversity and biogeochemical functioning in Arctic deep sea sediments
Although it has been proven that the Arctic is important in the present functioning of Earth and its life and is particularly sensitive to climate change, little is known about benthic ecosystem functioning in the Arctic Oceans. Therefore, to identify the variables structuring benthic functioning, during the summer of 2014 a bathymetric gradient was sampled on both sides of Fram Strait with multiyear ice in the west and a summer ice - free area in the east. The sampled variables included information about the environmental setting, fauna present and biogeochemical fluxes. Ice cover was found to determine the food availability, which in turn affected faunal density, macrofaunal community composition and bioirrigation rate. In summer ice - free areas underneath the marginal ice zone, food availability was higher and therefore meiofaunal density and bio - irrigation were higher as well. Macrofaunal density was only partly explained by food input and total oxygen uptake as a part of benthic remineralisation was mainly structured by silt fraction in the sediment. Water depth determined faunal community composition, with lower macrofaunal biomass and functional diversity in the deeper areas
An alternative approach for bioanalytical assay optimization for wastewater-based epidemiology of SARS-CoV-2
An alternative approach for bioanalytical assay optimization for wastewater-based epidemiology of SARS-CoV-2
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
Abstract Background While neurogranin has no value as plasma biomarker for Alzheimer’s disease, it may be a potential blood biomarker for traumatic brain injury. This evokes the question whether there are changes in neurogranin levels in blood in other conditions of brain injury, such as acute ischemic stroke (AIS). Methods We therefore explored neurogranin in paired cerebrospinal fluid (CSF)/plasma samples of AIS patients (n = 50) from a well-described prospective study. In parallel, we investigated another neuronal protein, i.e. tau, which has already been suggested as potential AIS biomarker in CSF and blood. ELISA as well as Single Molecule Array (Simoa) technology were used for the biochemical analyses. Statistical analyses included Shapiro-Wilk testing, Mann-Whitney analyses and Pearson’s correlation analysis. Results In contrast to tau, of which high levels in both CSF and plasma were related to stroke characteristics like severity and long-term outcome, plasma neurogranin levels were only correlated with infarct volume. Likewise, CSF neurogranin levels were significantly higher in patients with an infarct volume > 5 mL than in patients with smaller infarct volumes. Finally, neurogranin and tau were significantly correlated in CSF, whereas a weaker relationship was observed in plasma. Conclusions These findings indicate that although plasma and CSF neurogranin may reflect the volume of acute cerebral ischemia, this synaptic protein is less likely to be a potential AIS biomarker. Levels of tau correlated with severity and outcome of stroke in both plasma and CSF, in the present study as well as previous reports, confirming the potential of tau as an AIS biomarker
Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia
We aimed to evaluate the specificity of neurogranin (Ng) for Alzheimer's disease (AD) in a dementia cohort. Cerebrospinal fluid (CSF) Ng was measured (ELISA) in two independent cohorts: (1) clinical (n = 116; age 72±11 years): AD, non-AD (+high T-tau), and controls; and (2) autopsy-confirmed (n = 97; age 71±11 years): AD and non-AD, and 50 controls (age 60±6 years). In 16 autopsy-confirmed AD and 8 control subjects, Ng was measured in tissue (BA6+BA22). Ng was compared across diagnostic groups or neuropathological staging using multilinear regression models. Median[IQR] Ng concentrations were elevated in AD (414[315–499]pg/mL) and non-AD (464[319–699]pg/mL) compared to controls (260[193–306]pg/mL), but highest in AD-high-T-tau (874[716, 1148] pg/mL) and Creutzfeldt-Jakob disease (CJD; 828[703–1373]pg/mL) in cohort 1 (p < 0.01), but not in cohort 2: AD: 358[249–470]pg/mL; non-AD:245[137–416]pg/mL; controls: 259[193–370]pg/mL. Ng and tau biomarkers strongly correlated (r = 0.4–0.9, p < 0.05), except in CJD. CSF Ng concentrations were not associated with neuropathological AD hallmarks, nor with tissue Ng concentrations. CSF Ng is a general biomarker for synaptic degeneration, strongly correlating with CSF tau, but without added value for AD differential diagnosis